(Q38475312)

3 September 2017

title

Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability (English)

1 reference

3 September 2017

1 reference

1 reference

Soon Wook Hong

1

1 reference

3 September 2017

Bong Sang Lee

2

1 reference

3 September 2017

Su Jun Park

3

1 reference

3 September 2017

Hong Ryeol Jeon

4

1 reference

3 September 2017

Ki Young Moon

5

1 reference

3 September 2017

Mean Hyung Kang

6

1 reference

3 September 2017

Sang Han Park

7

1 reference

3 September 2017

Sung-Up Choi

8

1 reference

3 September 2017

Woo Heon Song

9

1 reference

3 September 2017

Jaehwi Lee

10

1 reference

3 September 2017

Young Wook Choi

11

1 reference

3 September 2017

language of work or name

1 reference

1 January 2011

1 reference

Archives of Pharmacal Research

3 September 2017

published in

1 reference

3 September 2017

volume

34

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

127-135

1 reference

Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Improving the high variable bioavailability of griseofulvin by SEDDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Pluronic-g-poly(acrylic acid) copolymers as novel excipients for site specific, sustained release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Cyclodextrins as pharmaceutical solubilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Polymeric micelles in oral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

The utility of cyclodextrins for enhancing oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Pharmaceutical Applications of Solid Dispersion Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Nanosizing--oral formulation development and biopharmaceutical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Nanosizing: a formulation approach for poorly-water-soluble compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Development of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of flurogestone acetate in ovine plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Microcrystals for dissolution rate enhancement of poorly water-soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Solubilization of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-011-0115-2

10.1007/S12272-011-0115-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1028533971

0 references

1 reference